Here’s a breakdown of the key information from the provided text, organized for clarity:
1. The Breakthrough: PRIMA Implant
* What it is: A prosthetic eye device developed at Stanford Medicine that restores usable vision to people with untreatable vision loss.It’s the first device to achieve this, specifically restoring form vision (recognizing shapes and patterns).
* How it works:
* A small camera on glasses captures visual information.
* The camera projects this information as infrared light to a wireless chip implanted in the retina.
* The chip converts the infrared light into electrical signals.
* These signals bypass damaged photoreceptors and stimulate remaining retinal neurons, sending visual data to the brain.
* Key Feature: Operates wirelessly and is photovoltaic (powered by light),making it safe for placement under the retina.
2. Clinical Trial results
* Participants: 38 patients (over 60 years old) with advanced geographic atrophy (a form of age-related macular degeneration) and very poor vision (worse than 20/320).
* Success Rate: 27 of 32 participants regained the ability to read within a year.
* Visual Acuity: Some participants achieved vision comparable to 20/42 with adjustable zoom and contrast features.
* Advancement Timeline: Visual acuity improved over months of training after implantation.
3. Geographic Atrophy & the Target Condition
* What it is: An advanced stage of age-related macular degeneration that progressively destroys central vision.
* Prevalence: Affects over 5 million people worldwide and is a leading cause of irreversible blindness in older adults.
* Why PRIMA can definitely help: While photoreceptors are lost, many of the neurons that process visual information remain intact. PRIMA utilizes these surviving structures.
4. Development History
* The idea for the device originated about 20 years ago with Dr. Daniel Palanker.
* The project involved decades of research, prototypes, animal testing, and previous human trials.
5. Key People Involved
* Daniel Palanker,PhD: Professor of ophthalmology at Stanford Medicine and co-senior author of the study. Conceived the original idea.
* José-Alain Sahel, MD: Professor of ophthalmology at the university of Pittsburgh School of Medicine, co-lead of the research.
* frank holz, MD: University of Bonn (germany), lead author of the published study.
6. Publication
* The study findings were published in the New England Journal of Medicine on October 20th.
